Position in NVCR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,165,659
+$735,059 QoQ
Shares Held
274,961
-12.6% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#47
of 217 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $134,579,177 across 47 Medical Devices names. NVCR ranks #11 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
|
526,390 | $20,181,792 | |
| 2 | ABT |
Abbott Laboratories
|
191,459 | $17,372,989 | |
| 3 | BSX |
Boston Scientific Corp
|
387,250 | $16,527,829 | |
| 4 | PODD |
Insulet Corp
|
81,786 | $12,451,918 | |
| 5 | EW |
Edwards Lifesciences Corp
|
111,370 | $10,074,529 | |
| 6 | SYK |
Stryker Corp
|
28,828 | $9,076,207 | |
| 7 | MDT |
Medtronic plc
|
100,956 | $7,897,787 | |
| 8 | CERS |
Cerus Corp
|
2,406,330 | $7,026,482 |
All Filings in NVCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,165,659 | 274,961 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $3,430,600 | 314,734 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,900,133 | 378,974 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $732,292 | 56,679 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $864,172 | 48,549 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||